Pacira BioSciences, Inc. PCRX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $144.31M-9.0% | $158.55M+7.4% | $147.59M-50.9% | $300.48M+5.9% | $283.61M+2.5% | ||
| $57.87M-27.5% | $79.88M-19.1% | $98.75M-32.1% | $145.38M-30.8% | $210.02M+1.0% | ||
| $125.64M+1.3% | $124.07M+7.6% | $115.27M+0.8% | $114.37M+9.2% | $104.75M-7.6% | ||
| $150.37M-1.6% | $152.86M-3.1% | $157.68M+6.4% | $148.16M+10.8% | $133.75M+6.8% | ||
| $514.96M-6.0% | $547.97M-2.6% | $562.75M-24.5% | $745.61M-1.9% | $759.96M+2.0% | ||
| $136.28M-3.1% | $140.69M-4.5% | $147.39M-5.0% | $155.18M-5.6% | $164.45M-1.6% | ||
| $19.77M-2.2% | $20.21M-0.5% | $20.32M+0.1% | $20.3M-5.7% | $21.52M— | ||
| $319.49M-4.3% | $333.82M-4.1% | $348.14M-4.0% | $362.46M-3.8% | $376.78M-11.5% | ||
| $1.21B-4.5% | $1.26B-2.5% | $1.3B-15.6% | $1.54B-3.1% | $1.59B+2.1% | ||
| $14.01M-7.5% | $15.15M-14.3% | $17.69M-41.3% | $30.12M+30.0% | $23.17M+21.1% | ||
| $108.79M-9.8% | $120.59M+12.6% | $107.08M-65.8% | $313.16M-0.5% | $314.73M+1.6% | ||
| $367.66M-1.2% | $372.19M-1.2% | $376.72M+285% | $97.83M-3.6% | $101.49M-2.6% | ||
| $554.64M-3.0% | $571.81M+0.3% | $570.36M-26.8% | $779.5M-1.1% | $788.13M+1.7% | ||
| 250M0.0% | 250M0.0% | 250M0.0% | 250M0.0% | 250M+531,815% | ||
| -$196.41M+1.5% | -$199.32M+0.8% | -$200.96M+2.6% | -$206.39M-2.4% | -$201.54M+2.3% | ||
| $653.89M-5.7% | $693.11M-4.7% | $727.21M-4.0% | $757.77M-5.1% | $798.54M+2.6% | ||
| $1.21B-4.5% | $1.26B-2.5% | $1.3B-15.6% | $1.54B-3.1% | $1.59B+2.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pacira BioSciences, Inc.'s total assets?
- Pacira BioSciences, Inc. (PCRX) holds $1.2B in total assets, down 23.8% year over year.
- How much debt does Pacira BioSciences, Inc. have?
- Pacira BioSciences, Inc. carries $411.2M in total debt against $653.9M of shareholders' equity, a debt-to-equity ratio of 0.63.
- How much cash does Pacira BioSciences, Inc. have?
- Pacira BioSciences, Inc. holds $144.3M in cash and equivalents.
- Can Pacira BioSciences, Inc. cover its short-term obligations?
- Its current ratio is 4.73 — current assets exceed current liabilities.
- Where does Pacira BioSciences, Inc.'s balance sheet data come from?
- Every line is extracted from Pacira BioSciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
